FDA WARNING_LETTER - Apothecary Products, Inc. - September 30, 2009
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
During inspections from April 28 - June 1, 2009, and September 25 - 30, 2009, FDA determined Apothecary Products, Inc. manufactures contact lens cases (e.g., Econo-Mate, Soft Grip, Deluxe, Color-Mate Deluxe, Travel-Mate) which are medical devices. These devices are adulterated under section 501(f)(1)(B) of the Act because the firm lacks an approved Premarket Approval (PMA) or Investigational Device Exemption (IDE). The devices are also misbranded under section 502(o) for failure to submit a 510(k) premarket notification.
The firm's July 16, 2009, response to the FDA-483 observations (CAPA numbers 00106, 00105, 00104, 00103, 00102) was deemed incomplete. FDA requires submission of specific procedures and supporting documentation for corrective actions, including: procedure (b)(4) Incident Review (CAPA 00106), (b)(4) MDR Reporting working instruction (CAPA 00105), updated procedure (b)(4) and corrections to the complaint database (CAPAs 00104, 00103), and
- Office
- Detroit District Office
- Person
ID · 8272f00a-77da-4d90-b1bc-d32c8cdf8572
Full citation text and observation details available on the Dashboard.